Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
NAD(P)H:quinone acceptor oxidoreductase-1 (NQO1) is a ubiquitous flavin adenine dinucleotide-dependent flavoprotein that promotes obligatory two-electron reductions of quinones, quinonimines, nitroaromatics, and azo dyes. NQO1 is a multifunctional antioxidant enzyme whose expression and deletion are...
Enregistré dans:
Auteurs principaux: | Bhargav Shreevatsa, Chandan Dharmashekara, Vikas Halasumane Swamy, Meghana V. Gowda, Raghu Ram Achar, Vivek Hamse Kameshwar, Rajesh Kumar Thimmulappa, Asad Syed, Abdallah M. Elgorban, Salim S. Al-Rejaie, Joaquín Ortega-Castro, Juan Frau, Norma Flores-Holguín, Chandan Shivamallu, Shiva Prasad Kollur, Daniel Glossman-Mitnik |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f039d1eae82d4a3b8bc5c8c39db5e75f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
par: Rivera Martínez,César Andrés
Publié: (2012) -
NQO1 Enzyme and its Role in Cellular Protection; an Insight
par: Ahmed Atia, et autres
Publié: (2020) -
Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population
par: Imen Hemissi, et autres
Publié: (2021) -
Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence
par: Huan Liu, et autres
Publié: (2021) -
Characteristics of social media ‘detoxification’ in university students
par: Joseph El-Khoury, et autres
Publié: (2021)